Related Experiment Video

Updated: Jul 13, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Successful treatment with bosentan for severe digital ischaemia in limited cutaneous systemic sclerosis

Emma P K Yu, Andrew J K Ostor, Frances C Hall

    Annals of the Rheumatic Diseases
    |July 14, 2007
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Video Protocol of a Randomized Controlled Clinical Trial - Electrochemotherapy of Cutaneous Metastases with Reduced Dose Bleomycin (BLESS Trial)
    04:11

    A Video Protocol of a Randomized Controlled Clinical Trial - Electrochemotherapy of Cutaneous Metastases with Reduced Dose Bleomycin (BLESS Trial)

    Published on: June 9, 2026

    Related Experiment Videos

    Last Updated: Jul 13, 2026

    Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
    06:59

    Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

    Published on: August 26, 2025

    A Video Protocol of a Randomized Controlled Clinical Trial - Electrochemotherapy of Cutaneous Metastases with Reduced Dose Bleomycin (BLESS Trial)
    04:11

    A Video Protocol of a Randomized Controlled Clinical Trial - Electrochemotherapy of Cutaneous Metastases with Reduced Dose Bleomycin (BLESS Trial)

    Published on: June 9, 2026

    Related Concept Videos

    Peripheral Artery Disease III: Interprofessional Care01:27

    Peripheral Artery Disease III: Interprofessional Care

    Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
    Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

    Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

    Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
    ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...

    Articles linked to this work by shared authors, journal, and citation graph.

    Efficacy of upadacitinib in subgroups of patients with axial spondyloarthritis with early versus established disease.

    RMD open·2025

    Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial.

    The Lancet. Respiratory medicine·2023

    The prevalence and impact of polypharmacy in rheumatology.

    Rheumatology (Oxford, England)·2023

    Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2.

    RMD open·2022

    Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials.

    RMD open·2022

    Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician.

    Biologics : targets & therapy·2021

    HOXD13 links positional identity to primary cilia-dependent signalling in synovial fibroblasts.

    Annals of the rheumatic diseases·2026

    Predictive molecular signatures for successful tapering of canakinumab in systemic juvenile idiopathic arthritis.

    Annals of the rheumatic diseases·2026

    Estimating 2-year risk of first relapse in ANCA-associated vasculitis: derivation of a risk-prediction model based on participants in the PEXIVAS trial.

    Annals of the rheumatic diseases·2026

    MRI and ultrasound predictors of progression to inflammatory arthritis in anti-CCP-positive individuals with musculoskeletal symptoms without clinical synovitis: a prospective cohort study.

    Annals of the rheumatic diseases·2026

    Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design.

    Annals of the rheumatic diseases·2026

    Sequential disease activity assessment for predicting future treatment trajectories in patients with rheumatoid arthritis treated with JAK inhibitors: a group-based trajectory and landmark analysis.

    Annals of the rheumatic diseases·2026

    In vivo HSPC gene therapy of hemoglobinopathies without drug selection of corrected cells.

    bioRxiv : the preprint server for biology·2026

    Transdermal diagnosis and therapy using an integrated acoustofluidic patch.

    bioRxiv : the preprint server for biology·2026

    RNA trans-splicing treatment for Duchenne muscular dystrophy.

    bioRxiv : the preprint server for biology·2026

    Porous Polymeric Materials for Cell Delivery and Regenerative Therapy: Design Principles, AI-Assisted Optimization, and Clinical Translation.

    Advanced healthcare materials·2026

    Anatomical-molecular interaction in glioblastoma: subventricular zone involvement and MGMT-related survival benefit.

    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026

    Managing refractory herpes simplex keratitis.

    The British journal of ophthalmology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us